Michael D. Hooven, Director at AtriCure, Inc. (ATRC), sold 3,500 shares at $10.02 ($35K) on 2012-03-13, disclosed to the SEC on 2017-02-23.
Open-market sale of $35k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |
| ATRC | BUY | 2012-09-14 | $8K | — | Filing → |